Green Cross Health Limited (NZE:GXH)
New Zealand · Delayed Price · Currency is NZD | Market Cap | 214.14M +101.5% |
| Revenue (ttm) | 528.32M +3.8% |
| Net Income | 17.51M +48.7% |
| EPS | 0.12 +48.4% |
| Shares Out | 143.72M |
| PE Ratio | 12.26 |
| Forward PE | n/a |
| Dividend | 0.06 (4.05%) |
| Ex-Dividend Date | Dec 4, 2025 |
| Volume | 17,311 |
| Average Volume | 24,670 |
| Open | 1.480 |
| Previous Close | 1.480 |
| Day's Range | 1.470 - 1.490 |
| 52-Week Range | 0.730 - 1.540 |
| Beta | 0.23 |
| RSI | 63.22 |
| Earnings Date | May 27, 2026 |
About Green Cross Health
Green Cross Health Limited provides health care and advice services to communities in New Zealand. It operates through Pharmacy Services and Medical Services segments. The Pharmacy Services segment offers pharmacy services through stores, equity accounted investments, and franchise stores. It operates community pharmacies under the Unichem and Life Pharmacy brands. The Medical Services segment operates owned and equity accounted medical centres, and offers support services provided to its medical centres, as well as medical centres outside the ... [Read more]
Financial Performance
In fiscal year 2025, Green Cross Health's revenue was 523.76 million, an increase of 3.94% compared to the previous year's 503.92 million. Earnings were 15.98 million, an increase of 35.88%.
Financial StatementsNews
Sydney buyout firms in talks to buy GP clinics from Green Cross Health
Private equity dealmakers from both shops have received preliminary due diligence materials for the up-for-grabs medical clinics.
Green Cross Health Transcript: AGM 2025
The meeting highlighted solid financial growth, strategic expansion of health services, and ongoing investment in technology. Key governance changes, regulatory advocacy, and a focus on operational improvement were discussed, with all major resolutions put to a poll.